DREAMM-5 platform trial: Belantamab Mafodotin (GSK2857916; belamaf; BLENREP) in combination with five different novel agents in patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Weisel, K (author)

Richardson, PG (author)

Trudel, S (author)

show more...

Callander, N (author)

Nooka, A (author)

Song, K (author)

Uttervall, K (author)

Karolinska Institutet

Minnema, MC (author)

Rodriguez-Otero, P (author)

Struemper, H (author)

Yeakey, A (author)

de Oca, RM (author)

Smith, LM (author)

Jackson, N (author)

Kaisermann, M (author)

Im, E (author)

Basile, FG (author)

Ahlers, CM (author)

Holkova, B (author)

Gupta, I (author)

Kremer, BE (author)

Quach, H (author)

show less...

 (creator_code:org_t)

2021

2021

English.

In: ONCOLOGY RESEARCH AND TREATMENT. - 2296-5270. ; 44, s. 204-205

Related links:

http://kipublication...

• Conference paper (other academic/artistic)